Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Larsen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Gut|September 21, 2011
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysisSylvie Deuffic-Burban, Philippe Mathurin, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)|November 11, 2010
Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG studyLionel Piroth, Christine Larsen, Christine Binquet, et al.
BMC Infectious Diseases|October 30, 2019
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategyCécile Brouard, Leïla Saboni, Arnaud Gautier, et al.
Plos One|January 5, 2012
Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG StudyChristine Larsen, Marie-Laure Chaix, Yann Le Strat, et al.
Journal of Viral Hepatitis|October 20, 2018
Primary resistance of hepatitis B virus to nucleoside and nucleotide analoguesStéphane Chevaliez, Christophe Rodriguez, Lila Poiteau, et al.
Emerging Infectious Diseases|March 19, 2020
Rift Valley Fever Outbreak, Mayotte, France, 2018-2019Hassani Youssouf, Marion Subiros, Genevieve Dennetiere, et al.
European Journal of Epidemiology|August 28, 2004
Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European settingVincenzo Puro, Stefania Cicalini, Gabriella De Carli, et al.
Emerging Infectious Diseases|March 20, 2004
Introduction of SARS in France, March-April, 2003Jean-Claude Desenclos, Sylvie van der Werf, Isabelle Bonmarin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Gut|September 21, 2011
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysisSylvie Deuffic-Burban, Philippe Mathurin, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)|November 11, 2010
Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG studyLionel Piroth, Christine Larsen, Christine Binquet, et al.
BMC Infectious Diseases|October 30, 2019
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategyCécile Brouard, Leïla Saboni, Arnaud Gautier, et al.
Plos One|January 5, 2012
Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG StudyChristine Larsen, Marie-Laure Chaix, Yann Le Strat, et al.
Journal of Viral Hepatitis|October 20, 2018
Primary resistance of hepatitis B virus to nucleoside and nucleotide analoguesStéphane Chevaliez, Christophe Rodriguez, Lila Poiteau, et al.
Emerging Infectious Diseases|March 19, 2020
Rift Valley Fever Outbreak, Mayotte, France, 2018-2019Hassani Youssouf, Marion Subiros, Genevieve Dennetiere, et al.
European Journal of Epidemiology|August 28, 2004
Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European settingVincenzo Puro, Stefania Cicalini, Gabriella De Carli, et al.
Emerging Infectious Diseases|March 20, 2004
Introduction of SARS in France, March-April, 2003Jean-Claude Desenclos, Sylvie van der Werf, Isabelle Bonmarin, et al.
Pageof 2